Mettler-Toledo International Inc. (MTD) stock has been a mixed performer over the past year, according to a new analysis. The Greifensee, Switzerland-based company, which makes precision instruments and services for the Americas and beyond, has grown 14.4% over the past three months — outperforming the Nasdaq Composite ($NASX), which gained 2% over the same period. But the picture changes when you look at the full year.
MTD is up 2.8% over the past 52 weeks, while NASX is up 19.5%. That means the stock has underperformed the broader market over the longer term.
MTD’s Recent High Point
MTD stock reached its 52-week high of $1525.17 on Nov. 25, 2025. Since then, it has slipped 15.1% from that peak. The stock has been trading below its 200-day and 50-day moving averages since the start of this month.
That slide below the moving averages is worth watching. Technical traders often see that crossover as a warning sign, though it is not a signal to sell. The stock has outperformed the Nasdaq over the past three months, so the short-term trend remains positive.
The Q2 Earnings Story
The short-term outperformance can be traced back to MTD’s second-quarter 2026 results. Revenue for the quarter rose 4.5% from the previous year’s quarter to $1 billion, matching the Street’s forecasts. Adjusted EPS came in at $11.46, beating consensus estimates.
The company also raised its full-year adjusted EPS guidance to $47.33 at the midpoint, marking a 1.5% increase. Free cash flow margin came in at 27.5%, up from 21.6% in the year-ago quarter.
Revenue growth, EPS beats, and improved free cash flow all point to a healthy business. But the stock’s failure to keep pace with the broader market and with its peers raises questions about whether MTD is being fairly priced.
How MTD Compares to Peers
When compared to its peer in the diagnostics and research industry, Quest Diagnostics Incorporated (DGX) shares have surged 30.7% over the past 52 weeks. That performance far outpaces MTD’s 2.8% gain.
The comparison shows a gap between the two companies’ stock movements. While MTD delivered strong quarterly numbers, its share price has lagged behind a rival that has posted stronger gains over the past year.
The Analyst Consensus
Wall Street’s view of MTD stock is somewhat bullish. Among the 15 analysts covering the stock, the overall consensus rating is “Moderate Buy.”
The mean price target of $1,464.60 offers a 13.7% upside potential.
What Investors Should Watch
The recent slide below the 200-day and 50-day moving averages is worth watching. Technical traders often see that crossover as a warning sign, though it is not a signal to sell. The stock has outperformed the Nasdaq over the past three months, so the short-term trend remains positive.
The Q2 results were solid. Revenue growth, EPS beats, and improved free cash flow all point to a healthy business. But the stock’s failure to keep pace with the broader market and with its peers raises questions about whether MTD is being fairly priced.
“Among the 15 analysts covering the stock, the overall consensus rating is “Moderate Buy.””
The Bottom Line on MTD
MTD stock is a large-cap stock with a market cap of $25.9 billion. It fits into the category of companies with a market cap of $10 billion or more, which are typically referred to as “large-cap stocks.”
The stock has outperformed the Nasdaq over the past three months but underperformed over the past 52 weeks. That split is the core of the question the headline poses: Is MTD underperforming the Nasdaq?
The answer depends on your time frame. Over three months, the stock has beaten the index. Over a year, it has trailed badly. The technical indicators suggest caution, but the fundamentals remain strong.
For investors holding MTD, the short-term picture looks favorable. For those considering buying, the question is whether the stock can break its recent slide and catch up to the Nasdaq’s longer-term gains.
The analyst target of $1,464.60 implies room to run, but the path to getting there is uncertain. The stock has underperformed the broader market over the past year, and the technical picture suggests further pressure could be ahead.
Here is the key takeaway:
- MTD stock has grown 14.4% over the past three months, outperforming the Nasdaq’s 2% gain
- MTD is up 2.8% over the past 52 weeks, while NASX is up 19.5%
- MTD hit its 52-week high of $1525.17 on Nov. 25, 2025, and has slipped 15.1% from that peak
- The stock has traded below its 200-day and 50-day moving averages since the start of this month
- Q2 revenue rose 4.5% to $1 billion, matching forecasts
- Adjusted EPS came in at $11.46, beating estimates
- Full-year adjusted EPS guidance was raised to $47.33 at the midpoint, a 1.5% increase
- Free cash flow margin rose to 27.5%, up from 21.6% a year earlier
- Analyst consensus is “Moderate Buy” with a mean price target of $1,464.60, implying 13.7% upside
The stock’s recent weakness and its underperformance against the broader market raise doubts about its near-term prospects. But the company’s financial health remains intact, and the analyst target suggests the stock has room to rise. Investors should weigh the technical picture against the fundamentals before making a decision.
Get the Notebook.
The day's best stories and every fresh verdict, in plain English, in your inbox by seven. One email a day, no more.